Wave Life Sciences Ltd.
NASDAQ:WVE
Overview | Financials
Company Name | Wave Life Sciences Ltd. |
Symbol | WVE |
Currency | USD |
Price | 12.24 |
Market Cap | 1,866,844,800 |
Dividend Yield | 0% |
52-week-range | 3.5 - 16.74 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Paul B. Bolno M.B.A., M.D., MBA |
Website | https://www.wavelifesciences.com |
An error occurred while fetching data.
About Wave Life Sciences Ltd.
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD